Quaking and miR-155 interactions in inflammation and leukemogenesis
暂无分享,去创建一个
C. Croce | S. Volinia | A. Laganà | L. Rassenti | T. Kipps | Taewan Kim | Hui-Lung Sun | Dario Veneziano | E. Tili | J. Michaille | D. Palmieri | Hamdy Awad | Timothy K Richmond | R. Cui | Tyler Sheetz | Marcela A. Chiabai | Melissa Brown | Cecilia Fernandes
[1] E. Flemington,et al. miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling , 2014, Genes & cancer.
[2] S. Ludwin,et al. miR‐155 as a multiple sclerosis–relevant regulator of myeloid cell polarization , 2013, Annals of neurology.
[3] Timothy A. Miller,et al. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. , 2013, Human molecular genetics.
[4] G. Calin,et al. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. , 2013, Blood.
[5] J. Arthur,et al. Mitogen-activated protein kinases in innate immunity , 2013, Nature Reviews Immunology.
[6] Guido Marcucci,et al. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] G. Calin,et al. Signal Transducer and Activator of Transcription–3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia , 2013, PloS one.
[8] C. Croce,et al. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer , 2013, Immunological reviews.
[9] E. Vigorito,et al. miR‐155: an ancient regulator of the immune system , 2013, Immunological reviews.
[10] Valeria Mezzolla,et al. Potential of Anti‐Cancer Therapy Based on Anti‐miR‐155 Oligonucleotides in Glioma and Brain Tumours , 2013, Chemical biology & drug design.
[11] C. Croce,et al. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. , 2012, Blood.
[12] Shizuo Akira,et al. Dissecting negative regulation of Toll-like receptor signaling. , 2012, Trends in immunology.
[13] S. Marsigliante,et al. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. , 2012, International journal of oncology.
[14] Yonghong Xiao,et al. STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA. , 2012, Genes & development.
[15] Christopher J. Cheng,et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.
[16] Christian Ehlting,et al. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. , 2012, Cellular signalling.
[17] Jianyong Sun,et al. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis. , 2012, Biochemical and biophysical research communications.
[18] Guodong Yang,et al. The RNA-binding protein QKI5 is a direct target of C/EBPα and delays macrophage differentiation. , 2012, Molecular biology of the cell.
[19] Guanghui Wang,et al. miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer , 2012, Gut.
[20] George A. Calin,et al. GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials , 2010, Nucleic acids research.
[21] Susan R. Quinn,et al. IL-10 Inhibits miR-155 Induction by Toll-like Receptors* , 2010, The Journal of Biological Chemistry.
[22] D. Iliopoulos,et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.
[23] C. Croce,et al. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. , 2009, Blood.
[24] C. Hother,et al. Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas , 2009, EMBO molecular medicine.
[25] Ryan M. O’Connell,et al. Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.
[26] Manuel A. S. Santos,et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells , 2009, Proceedings of the National Academy of Sciences.
[27] C. Croce,et al. miR-155: On the Crosstalk Between Inflammation and Cancer , 2009, International reviews of immunology.
[28] P. Sharp,et al. Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.
[29] Muller Fabbri,et al. Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.
[30] David Baltimore,et al. MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.
[31] E. Haralambieva,et al. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. , 2005 .
[32] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[33] S. Richard,et al. Target RNA motif and target mRNAs of the Quaking STAR protein , 2005, Nature Structural &Molecular Biology.
[34] S. Richard,et al. QUAKING KH Domain Proteins as Regulators of Glial Cell Fate and Myelination , 2005, RNA biology.
[35] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[36] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[37] S. Richard,et al. Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer. , 2001, Genes & development.
[38] M. Besson,et al. The quaking mouse: an epileptic mutant with alterations affecting the modulatory mechanisms of the NMDA receptor complex , 1991, Brain Research.
[39] Yue Feng,et al. The star family member QKI and cell signaling. , 2010, Advances in experimental medicine and biology.
[40] Guodong Yang,et al. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. , 2010, Gastroenterology.
[41] H. Taubert,et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival , 2010, International journal of cancer.
[42] Yue Feng,et al. The Star Family Member , 2010 .
[43] Stefano Volinia,et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] Jiahuai Han,et al. Essential role of p38gamma in K-Ras transformation independent of phosphorylation. , 2005, The Journal of biological chemistry.